Records containing: Malaria, Vivax
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-20Health Care Provider Use of Plasmodium Vivax Radical Cure (RC) With Tafenoquine or Primaquine After Semi-quantitative G6PD Testing: A Feasibility Study in Peru
-
CLINICAL_TRIALS study record update · 2026-01-15A Phase Ia Study to Assess Safety and Immunogenicity of the Plasmodium Vivax Malaria Vaccine Candidate Pvs25-IMX313 in Matrix-M1 Adjuvant in Healthy Adults Living in the UK
-
CLINICAL_TRIALS study record update · 2026-01-06Mass Drug Administration of Tafenoquine for P. Vivax Radical Cure: Safety and Feasibility Study
-
CLINICAL_TRIALS study record update · 2025-08-07A Randomized, Open-label, Multi-center, Interventional Phase 3 Study of the Efficacy and. Safety of Tafenoquine Compared to Primaquine (Both Co-administered With Chloroquine) for the Radical Cure (Relapse Prevention) of Plasmodium Vivax (P. Vivax) Malaria in Indian Participants (Pediatric and Adult Population)
-
CLINICAL_TRIALS study record update · 2025-07-24Radical CUREfor MAlaria Among Highly Mobile and Hard-to-reach Populations in the Guyanese Shield
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-05-16Does Artemisinin Combination Treatment Reduce the Radical Curative Efficacy of High Dose Tafenoquine for Plasmodium Vivax Malaria?
-
CLINICAL_TRIALS study record update · 2025-04-25VAC069: A Clinical Study to Assess the Safety and Feasibility of Controlled Blood-stage Plasmodium Vivax Human Malaria Infection Through Experimental Inoculation of Cryopreserved Infected Erythrocytes in Healthy Malaria-naïve UK Adults
-
CLINICAL_TRIALS study record update · 2025-02-20Phase IIB Study to Evaluate Primaquine Safety and Tolerability for Radical Cure of Uncomplicated Plasmodium Vivax Malaria in Children < 15 Years-old (CHILDPRIM)
-
CLINICAL_TRIALS study record update · 2024-11-25A Phase I/IIa Clinical Trial to Assess the Safety, Immunogenicity and Efficacy of the Blood-stage Plasmodium Vivax Malaria Vaccine Candidate PvDBPII in Matrix M1 in Healthy Adults Living in the UK
-
CLINICAL_TRIALS study record update · 2024-10-08Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine - a Randomized Controlled Trial in P. Vivax Patients
-
CLINICAL_TRIALS study record update · 2024-08-29Short Course Radical Cure of P.Vivax in Nepal- a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-04-12A Phase IIa Challenge Study to Assess Efficacy of the Plasmodium Vivax Malaria Vaccine Candidates ChAd63 PvDBP and MVA PvDBP in Healthy Adults Living in the UK
-
CLINICAL_TRIALS study record update · 2023-12-04An Open Label Phase 2a Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of (+)-SJ000557733 (SJ733) With or Without Cobicistat in Adult Patients With Acute, Uncomplicated Malaria Over a 42 Day Period
-
CLINICAL_TRIALS study record update · 2023-10-26Operational Feasibility of Appropriate Plasmodium Vivax Radical Cure With Tafenoquine or Primaquine After Quantitative G6PD Testing in Thailand
-
CLINICAL_TRIALS study record update · 2023-09-13Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua
-
CLINICAL_TRIALS study record update · 2023-06-29A Clinical Study to Assess the Safety of Controlled Human Plasmodium Vivax Malaria Infection Through Experimental Sporozoite Infection of Healthy Malaria-naïve UK Adults, and to Characterise Parasite Growth and Immune Responses to P.Vivax
-
CLINICAL_TRIALS study record update · 2023-06-13Operational Feasibility of Appropriate Radical Cure of Plasmodium Vivax With Tafenoquine or Primaquine After Quantitative G6PD Testing in Brazil
-
CLINICAL_TRIALS study record update · 2023-06-12An Open Label Randomized Comparative Study to Assess the Efficacy and Tolerability of Eurartesim® Versus Chloroquine and Nonrelapse Therapy With Primaquine for Uncomplicated Plasmodium Vivax Monoinfection Malaria
-
CLINICAL_TRIALS study record update · 2023-05-11Primaquine Double Dose for Radical Cure of Plasmodium Vivax in Colombia
-
CLINICAL_TRIALS study record update · 2023-04-13Plasmodium Vivax Burden, Range and Transmission Among Duffy Negative Inhabitants in Cameroon.
-
CLINICAL_TRIALS study record update · 2023-03-07Serological Screen and Treat Trial for P. Vivax: a Proof-of-concept Trial in Western Indonesia
-
CLINICAL_TRIALS study record update · 2021-11-12Developing a Methodology to Assess 8-aminoquinoline Associated Haemolytic Risk in Females Heterozygous for G6PD in Endemic Populations
-
CLINICAL_TRIALS study record update · 2021-08-09Efficacy of Three Regimens of Chloroquine and Primaquine for the Treatment of Plasmodium Vivax Malaria in Cruzeiro do Sul, Acre, Brazil
-
CLINICAL_TRIALS study record update · 2021-03-01Safety and Protective Efficacy of a Synthetic Vaccine Derived From the CS Protein of Plasmodium Vivax: a Double-blind, Placebo-controlled, Randomized Clinical Trial in naïve and Pre-immune Colombian Volunteers
-
CLINICAL_TRIALS study record update · 2020-11-02An Open Label, Non-comparative, Multicenter Study to Assess the Pharmacokinetics, Safety and Efficacy of Tafenoquine (SB-252263, WR238605) in the Treatment of Pediatric Subjects With Plasmodium Vivax Malaria